Syndax Pharmaceuticals Reports Fourth Quarter and Year-end 2016 Financial Results and Provides Clinical and Business Update

Go back to Syndax Pharmaceuticals Reports Fourth Quarter and Year-end 2016 Financial Results and Provides Clinical and Business Update
(NASDAQ: SNDX) Delayed: 17.86 +0.24 (1.36%)
Previous Close $17.62    52 Week High $18.03 
Open $17.75    52 Week Low $8.97 
Day High $17.86    P/E N/A 
Day Low $17.39    EPS $0.00 
Volume 69,231